Abel Ang

Title: Innovations by Abel Ang in Conditioned Media Technology

Introduction

Abel Ang is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of biomedical technology, particularly in the development of conditioned media derived from umbilical cord tissue. His innovative approach has the potential to enhance various applications in regenerative medicine.

Latest Patents

Abel Ang holds a patent for "Conditioned media and methods of making a conditioned media." This patent describes a stable and scalable process for manufacturing reduced serum umbilical cord tissue-derived (UTC)-conditioned media. The method involves culturing UTC under reduced serum conditions, followed by washing and growing the UTC in serum-free basal media. After approximately 24 hours, the conditioned media is collected, filtered, and concentrated using an approximately 5 kDa or similar cut-off membrane. This innovative process is crucial for advancing research and applications in the medical field.

Career Highlights

Abel Ang is currently employed at DePuy Synthes Products, Inc., where he continues to work on innovative solutions in the biomedical sector. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

Abel Ang collaborates with various professionals, including his coworker Alexander M Harmon. Their combined efforts contribute to the advancement of technologies that can significantly impact healthcare.

Conclusion

Abel Ang's work in developing conditioned media technology showcases his commitment to innovation in the biomedical field. His patent and ongoing contributions are paving the way for future advancements in regenerative medicine.